SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is generating intense community buzz as the stock holds steady near the $5 level amid heavy short interest and anticipation surrounding upcoming data updates at the AACR conference. Long-term shareholders remain focused on the potential for clinical trial readouts to trigger a significant revaluation, while actively debating the impact of upcoming options expiration and the feasibility of an early trial halt based on therapeutic efficacy.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as the stock surges following regulatory approval from Greenland to increase its stake in the Tanbreez rare earth project to over 90%. Investors are actively discussing the potential for a massive short squeeze and long-term revaluation, with many citing the strategic importance of the asset for Western supply chain independence and potential interest from institutional or government buyers.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Mining Inc

Cipher Mining is generating significant buzz as investors weigh its robust hyperscaler contract pipeline against recent sector-wide volatility and geopolitical headwinds. The community is actively debating the company's valuation gap compared to its peers, with many seeing the current price action as a potential accumulation zone while others express frustration over institutional selling patterns.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio Inc. (IBRX) is currently experiencing high volatility driven by a combination of speculative options activity and market-maker pressure, leading the community to intensely debate the legitimacy of ongoing legal noise versus the company's strong long-term clinical potential. While some investors are frustrated by persistent price suppression and technical pullbacks, the active community remains bullish, citing a powerful 'gamma squeeze' setup, imminent international commercial launches, and the potential for a breakout fueled by institutional accumulation.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors digest a series of positive clinical trial developments alongside optimism regarding upcoming institutional data and regulatory milestones. The community remains deeply divided, with long-term believers citing the company's platform potential and pipeline depth, while skeptical traders point to extended timelines and historical price volatility as key concerns.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion Inc. (INFQ) is surging on massive volume as investors pivot to the company following its strategic inclusion in NVIDIA's quantum ecosystem, positioning it as a significant partner for AI-integrated quantum hardware. Community sentiment is overwhelmingly bullish, with traders viewing the stock as an undervalued leader in neutral-atom technology and highlighting its strong pipeline of government and commercial contracts compared to sector peers.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing intense market volatility driven by aggressive short squeeze dynamics and speculative retail interest, with social sentiment divided between those chasing the parabolic momentum and traders anticipating a sharp correction. The discussion is dominated by concerns over potential institutional manipulation, the lack of fundamental justification for the rapid price appreciation, and widespread debates regarding the timing of an inevitable reversal.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is experiencing high-volatility price action and massive call option volume as investors position for potential regulatory approvals and a major data center power partnership. Community sentiment remains deeply divided between long-term bulls betting on the company's AI-linked energy infrastructure and vocal critics focused on the lack of current revenue, pending litigation, and speculative leadership.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is trending as investors rally behind a potential short squeeze, fueled by the SEC's recent removal of the restrictive Pattern Day Trader rule and the company's termination of a dilutive equity agreement. The community is actively debating the stock's massive upside potential, with many accumulating shares on dips in anticipation of a sustained run toward higher resistance levels.

Maulcoin

Maulcoin is trending as the community rallies around a "Mauling" culture, actively defending the project against copycat tokens while pushing for higher market cap milestones through coordinated buying challenges. Enthusiasts remain focused on long-term holding and transparent development, viewing recent price volatility as a buying opportunity amidst the broader meme coin season.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sudden, temporary vision loss is easy to dismiss, especially when it resolves quickly. But as a new article from NovaVision, the vision rehabilitation division of Vycor Medical, explains, it can be one of the earliest warning signs of an approaching stroke. A transient ischemic attack, or TIA, often produces brief vision changes, including dimming or complete loss of sight in one eye, that can signal something more serious ahead. 
 
Vycor Medical, Inc. (OTCQB: $VYCO) is a B2i Digital Featured Company. See the company’s complete profile at https://b2idigital.com/vycor-medical. 
 
The article explores how sudden vision changes can serve as early stroke warnings, what types of vision loss commonly follow a stroke, and what rehabilitation options are available. As the article notes: “If you experience sudden vision loss, whether in one eye or across part of your visual field, along with any other stroke-associated symptoms, seek medical attention immediately. Acting fast is the single most important thing you can do to reduce the impact of a stroke.” 
 
Read the full article here: https://novavision.com/vision-loss-as-a-warning-sign-of-stroke/ 
 
Vycor operates two divisions: Vycor Medical (ViewSite Brain Access System™ for neurosurgery) and NovaVision (vision rehabilitation therapies for stroke and brain injury patients). The company is led by CEO Peter Zachariou, President David Cantor, and CFO Adrian Liddell, each bringing extensive experience in medical technology, business development, and finance. More information is available at https://vycormedical.com/investors/. 
 
For investor inquiries, please contact info@vycormedical.com. 
 
Disclosure: David Shapiro, CEO of B2i Digital, personally purchased and currently owns shares of unrestricted VYCO stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. This post is not intended to solicit the sale of VYCO or any security, nor is it intended to offer any opinion on VYCO as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the full disclosure in the Risks and Disclosures section of https://b2idigital.com/disclaimer. $CTSO, $SNWV, $IHI

David Shapiro

Brogley Panzarella

Ball Terjova

Allie Walker

Bana Daerhova

Refugio Bergstrom

top moon

Mangine Mckelvy

Cal Dwan

James

Tyree

Prince

Julio

Dwight

Pablo Rodriguez

Ariana Storck

Craig Salinas

Henry Callaghan

John Park

Jeanne Hodges

Kelly Distaffen

Renee Blankenship

Nina Studdard

Filomena Marsh

Vycor Medical, Inc. is dedicated to providing the medical community with innovative and superior neurosurgical and neurotherapeutic solutions.

B2idigital

Vycor Medical on b2i Digital

Most discussions of stroke and vision focus on what happens afterward, particularly the lasting changes that affect daily life. But sudden, temporary vision changes can also be an early warning that a stroke is approaching. Recognizing these signs and acting quickly can make a real difference.

NovaVision

Vision Loss as a Warning Sign of Stroke - NovaVision

View Vycor Medical's investor information, including SEC filings, financial data, company updates, and insights into VBAS and NovaVision technologies.

Vycor

Investors - Vycor

Disclaimer - Content is provided "as is" by companies featured on the site. Conduct a trusted advisory before making investments.

Disclaimer - Consult and advisor before making any investments

StockTwits Web

Cytosorbents Corp

SANUWAVE Health, Inc.

iShares US Medical Devices ETF

Sudden, temporary vision loss is easy to dismiss, especially when it resolves quickly. But as a new article from NovaVision, the vision rehabilitation division of Vycor Medical, explains, it can be one of the earliest warning signs of an approaching stroke. A transient ischemic attack, or TIA, often produces brief vision changes, including dimming or complete loss of sight in one eye, that can signal something more serious ahead. 
 
Vycor Medical, Inc. (OTCQB: $VYCO) is a B2i Digital Featured Company. See the company’s complete profile at 

. 
 
The article explores how sudden vision changes can serve as early stroke warnings, what types of vision loss commonly follow a stroke, and what rehabilitation options are available. As the article notes: “If you experience sudden vision loss, whether in one eye or across part of your visual field, along with any other stroke-associated symptoms, seek medical attention immediately. Acting fast is the single most important thing you can do to reduce the impact of a stroke.” 
 
Read the full article here: 

 
 
Vycor operates two divisions: Vycor Medical (ViewSite Brain Access System™ for neurosurgery) and NovaVision (vision rehabilitation therapies for stroke and brain injury patients). The company is led by CEO Peter Zachariou, President David Cantor, and CFO Adrian Liddell, each bringing extensive experience in medical technology, business development, and finance. More information is available at 

. 
 
For investor inquiries, please contact info@vycormedical.com. 
 
Disclosure: David Shapiro, CEO of B2i Digital, personally purchased and currently owns shares of unrestricted VYCO stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. This post is not intended to solicit the sale of VYCO or any security, nor is it intended to offer any opinion on VYCO as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the full disclosure in the Risks and Disclosures section of 

Applied Energetics, Inc.

Nasdaq Inc

NASDAQ Composite

SuperCom Ltd

Genvor Inc

OS Therapies Inc

eXoZymes Inc.

Kolibri Global Energy Inc

Sudden vision loss can be an early warning sign of stroke, and NovaVision’s latest article highlights why recognizing these symptoms early matters. 
 
As a B2i Digital Featured Company, Vycor Medical is advancing both neurosurgical access and vision rehabilitation solutions. 
 
See Vycor Medical’s full profile here: 
https://b2idigital.com/vycor-medical

Sudden vision loss can be an early warning sign of stroke, and NovaVision’s latest article highlights why recognizing these symptoms early matters. 
 
As a B2i Digital Featured Company, Vycor Medical is advancing both neurosurgical access and vision rehabilitation solutions. 
 
See Vycor Medical’s full profile here: 
